Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Physiologically Guided Ablation of Reentry-Vulnerable-Zones for the Treatment of Post-Infarction Ventricular Tachycardia

NCT04004624 is registered in ClinicalTrials.gov with Center for Cardiovascular Reseach and Innovation as lead sponsor.

NCT NCT04004624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04004624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Physiologically Guided Ablation of Reentry-Vulnerable-Zones for the Treatment of Post-Infarction Ventricular Tachycardia
Lead sponsor
Center for Cardiovascular Reseach and Innovation
Phase
Not applicable
Overall status
Unknown status
Start date
October 12, 2014
Completion date
January 1, 2020
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular tachycardia